Advances in LLM. Prognostic factors in multiple myeloma

Clinical Advances in Hematology and Oncology

Volumn 3, Issue 3, 2005, Pages 167-168

  Tricot, Guido ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; ANTINEOPLASTIC AGENT; ONCOPROTEIN; TUMOR MARKER; TUMOR PROTEIN;

ARTICLE; BONE DESTRUCTION; CANCER CELL; CANCER GENETICS; CANCER RISK; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; CHROMOSOME 1Q; CHROMOSOME TRANSLOCATION; CYTOGENETICS; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; GENE EXPRESSION PROFILING; GENETIC PREDISPOSITION; GENETIC VARIABILITY; HIGH RISK POPULATION; HUMAN; KARYOTYPING; MULTIPLE MYELOMA; PROGNOSIS; BIOSYNTHESIS; CHROMOSOME ABERRATION; DRUG DELIVERY SYSTEM; GENE TRANSLOCATION; GENETICS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOTHERAPY; MORTALITY; PATIENT SELECTION;

ANTINEOPLASTIC AGENTS; CHROMOSOME ABERRATIONS; DRUG DELIVERY SYSTEMS; GENE EXPRESSION PROFILING; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOTHERAPY; KARYOTYPING; MULTIPLE MYELOMA; NEOPLASM PROTEINS; ONCOGENE PROTEINS, FUSION; PATIENT SELECTION; PROGNOSIS; TRANSLOCATION, GENETIC; TUMOR MARKERS, BIOLOGICAL;

EID: 25844439326     PISSN: 15430790     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (2)

1. Fassas AB, Tricot G. Chromosome 13 deletion/hypodiploidy and prognosis in multiple myeloma patients. Leuk Lymphoma. 2004;45(6):1083-1091.
2. Fassas AB, Ward S, Muwalla F, et al. Myeloma of the central nervous system: strong association with unfavorable chromosomal abnormalities and other high-risk disease features. Leuk Lymphoma. 2004;45(2):291-300.